BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 2573212)

  • 1. Multiple action compounds in angina pectoris.
    Kelly DT; Freedman SB
    Z Kardiol; 1989; 78 Suppl 3():16-20. PubMed ID: 2573212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carvedilol versus verapamil in chronic stable angina: a multicentre trial.
    Hauf-Zachariou U; Blackwood RA; Gunawardena KA; O'Donnell JG; Garnham S; Pfarr E
    Eur J Clin Pharmacol; 1997; 52(2):95-100. PubMed ID: 9174677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of carvedilol in patients with impaired left ventricular function due to ischaemic heart disease.
    Lahiri A; Rodrigues EA; DasGupta P; Jain D; van der Does R; Raftery EB
    Z Kardiol; 1989; 78 Suppl 3():21-7. PubMed ID: 2573213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of carvedilol in comparison with nifedipine sustained-release in chronic stable angina.
    van der Does R; Eberhardt R; Derr I; Ehmer B
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S122-7. PubMed ID: 1378139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antianginal efficacy of carvedilol, a new beta-blocker with vasodilating action.
    Jamal SM; Freedman SB; Thomson A; Carter G; Harris PJ; Kelly DT
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S141-6. PubMed ID: 2454361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of chronic stable angina with carvedilol: a multiple-action neurohormonal antagonist. A review of controlled clinical trials.
    González Maqueda I
    J Int Med Res; 1998; 26(3):107-19. PubMed ID: 9718465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a new vasodilating beta-blocking agent, carvedilol, in exertional angina using holter monitoring.
    Kishida H; Saito T; Fukuma N; Hata N; Suzuki T; Ohtsu F
    Jpn Heart J; 1990 Jul; 31(4):449-60. PubMed ID: 1977939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carvedilol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.
    McTavish D; Campoli-Richards D; Sorkin EM
    Drugs; 1993 Feb; 45(2):232-58. PubMed ID: 7681374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Anginal and Metabolic Effects of Carvedilol and Atenolol in Patients with Stable Angina Pectoris: A Prospective, Randomized, Parallel, Open-Label Study.
    Oh PC; Kang WC; Moon J; Park YM; Kim S; Kim MG; Lee K; Ahn T; Shin EK
    Am J Cardiovasc Drugs; 2016 Jun; 16(3):221-8. PubMed ID: 27021556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasodilating beta-blockers in heart failure.
    Raftery EB
    Eur Heart J; 1995 Jul; 16 Suppl F():32-7. PubMed ID: 8521882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of carvedilol and atenolol efficacy in patients with stable effort angina].
    Martsevich SIu; Koniakhina IP; Alimova EV; Kutishenko NP; Lerman OV
    Ter Arkh; 2001; 73(1):38-41. PubMed ID: 11234138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The preventative effects of vasodilating beta-blockers in cardiovascular disease.
    Raftery EB
    Eur Heart J; 1996 Apr; 17 Suppl B():30-8. PubMed ID: 8733069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of chronic stable angina with carvedilol in comparison with nifedipine s.r.
    van der Does R; Eberhardt R; Derr I; Ehmer B; Rudorf J; Uberbacher HJ
    Eur Heart J; 1991 Jan; 12(1):60-4. PubMed ID: 2009895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacology of multiple action compounds.
    Prichard BN; Tomlinson B
    Z Kardiol; 1989; 78 Suppl 3():1-6. PubMed ID: 2573211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carvedilol in ischaemic heart disease.
    Prichard BN
    Cardiology; 1993; 82 Suppl 3():34-9. PubMed ID: 8106163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carvedilol.
    Frishman WH
    N Engl J Med; 1998 Dec; 339(24):1759-65. PubMed ID: 9845712
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy of carvedilol in exercise-induced myocardial ischemia.
    Kaski JC; Rodriguez-Plaza L; Brown J; Maseri A
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S137-40. PubMed ID: 2454360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy and tolerability of felodipine and nifedipine in stable angina refractory to beta-blocker therapy].
    Mazzotta G; Falcidieno M; Ravera E; Vecchio C
    G Ital Cardiol; 1996 Apr; 26(4):407-17. PubMed ID: 8707025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of nipradilol on the patients of angina pectoris: results from the study of the exercise electrocardiography using HR-ST loop method].
    Maehara K; Morita M; Fukushima T; Sakurai K; Koseki Y; Takishima T
    Kokyu To Junkan; 1993 Mar; 41(3):255-60. PubMed ID: 8097055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-blockers in heart failure. Do they improve the quality as well as the quantity of life?
    Fowler MB
    Eur Heart J; 1998 Dec; 19 Suppl P():P17-25. PubMed ID: 9886708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.